Goldman Sachs maintains a Buy rating on Puig Brands S.A., with a 12-month target price of €21.50

Overview

This is a Goldman Sachs company research/earnings preview report on Puig Brands S.A., focused primarily on the impact of Q3 fragrance new product launches on accelerating growth. The report notes that the new Jean Paul Gaultier women's fragrance La Favorite, the 1 Million Black extension, and potential subsequent launches from Rabanne and others will continue to drive company growth as category growth normalizes.

Core views

Goldman Sachs maintains its Buy rating on Puig, believing that Q3 new product launches, easier year-over-year comparisons, and category earnings seasonality will together improve fragrance growth and EBITDA delivery visibility. The report also believes the market has not fully reflected Puig's medium-term growth potential and balance-sheet optionality.

Analysis framework

The report analyzes the new product pipeline, year-over-year fragrance category comparison base, competitors' launch plans, valuation multiples, and DCF, and compares Puig's fragrance launch cycle with those of peers such as L’Oréal and Interparfums.

Methodology notes

• Valuation methodsBlended DCF and Relative Valuation Approach

  The target price is derived using equal 50% weights for DCF and multiples-based valuation.

  Goldman Sachs assumes an 8.5% WACC and a 2.5% perpetual growth rate in its DCF, resulting in an intrinsic value of €22.8 per share; the multiples-based approach applies a 16.5x P/E to Q5-Q8 EPS, resulting in €20.3 per share. The blended result is rounded to a €21.50 target price.

• Factor AnalysisGS Factor Profile

  Measures a stock's relative characteristics through growth, financial returns, valuation multiples, and composite factors.

  The growth factor uses forward sales, EBITDA, and EPS growth; financial returns use ROE, ROCE, and CROCI; valuation multiples use metrics such as P/E, P/B, and EV/EBITDA; the composite factor combines growth, financial returns, and low-valuation characteristics.

• M&A FrameworkM&A Rank

  Goldman Sachs classifies a company's potential acquisition probability into three tiers from 1 to 3.

  This report discloses an M&A Rank of 3 for Puig, indicating a low probability of acquisition and generally not incorporated into the target price.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

• Puig Brands S.A. (PUIGb.MC)

  Research subject

  Strengths

  Owns fragrance brands such as Jean Paul Gaultier and Rabanne and has a continuing new product pipeline; Q3 fragrance launches and an easier year-over-year comparison base could accelerate growth.

  Weaknesses

  The company remains relatively dependent on a small number of major fragrance franchises, while entering niche fragrances could increase portfolio complexity and A&P investment.

  Comparison

  The report notes that L’Oréal may launch Valentino Vendetta and a new Armani franchise, while Interparfums may also pursue a more aggressive launch plan in FY27, indicating intensifying competition in new product launches across the industry.

  Risks

  Macroeconomic weakness affecting demand, intense competition, M&A integration execution, the cost of expansion in Asia, foreign exchange, and tariffs could all affect the investment case.

• Jean Paul Gaultier La Favorite

  Key new product catalyst

  Strengths

  Expected to launch in Europe in early August, potentially driving Q3 fragrance growth.

  Weaknesses

  Performance depends on market acceptance and execution of promotional activities.

  Comparison

  Together with 1 Million Black and other extensions, it forms part of the Q3 fragrance launch pipeline.

  Risks

  A slower launch schedule or weaker-than-expected consumer response could reduce its Q3 growth contribution.

• 1 Million Black

  Extension product launch

  Strengths

  Launching in Europe and planned for the US in early September, potentially expanding the contribution from the Rabanne/1 Million franchise.

  Weaknesses

  Growth durability for an extension may be lower than for an entirely new franchise.

  Comparison

  FY26 plans include two 1 Million extensions, compared with one in FY25.

  Risks

  Intensifying competition among fragrance extensions could affect sell-in and margins.

Key data

• 12-month target price€21.50Derived using equal 50% weights for DCF and multiples-based valuation.
• Current price€16.74Price disclosed on the report cover.
• Implied upside28.4%Based on the target price and current price.
• Q3 organic fragrance sales growth forecast7.5%Goldman Sachs forecast, above Visible Alpha consensus of 6.1%.
• Q2 organic sales growth forecast3.7%Goldman Sachs expects Q2 organic sales growth, reported on July 30, to be in line with consensus.
• Market capitalization€9.4bn / $10.8bnDisclosed in Key Data.
• Enterprise value€10.1bn / $11.6bnDisclosed in Key Data.
• CY27e P/E14xThe report believes this valuation does not fully reflect medium-term growth potential.

Impact & implications

If Q3 new product launches proceed as expected, Puig's fragrance business may maintain higher growth during the industry's normalization phase and improve full-year EBITDA delivery visibility through stronger Q3 earnings contribution. From an investment perspective, Goldman Sachs believes the current share price still offers upside potential, with key catalysts including new product sell-in, Q2 results, and the subsequent FY27/FY28 blockbuster product pipeline.

Risks

• An economic downturn could cause volatility in fragrance demand.
• Competition remains intense, and Puig has relatively high dependence on a small number of major franchises.
• Expanding the niche fragrance portfolio could increase complexity and require higher A&P investment.
• Acquired asset integration entails execution risk, and overly high acquisition prices may emerge in competitive markets.
• Expansion in China and broader Asia could be costly and scale more slowly.
• Foreign exchange fluctuations could affect results and valuation.
• Tariff risks could affect costs and margins.

What to watch

• Q2 results on July 30, with particular focus on whether organic sales growth is close to Goldman Sachs' 3.7% forecast.
• The performance and channel sell-in feedback for La Favorite following its early-August launch in Europe.
• The launch pace of 1 Million Black in Europe and the US.
• Potential FY27 Rabanne blockbuster products and progress on a new men's fragrance franchise in FY28.
• Whether Q3 fragrance growth reaches Goldman Sachs' 7.5% forecast and exceeds market expectations.
• Changes in EBITDA delivery visibility and A&P investment intensity.